Immediate Impact

52 standout
Sub-graph 1 of 22

Citing Papers

Risk of Autism after Prenatal Topiramate, Valproate, or Lamotrigine Exposure
2024 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
2 intermediate papers

Works of Tabea Wilhelm being referenced

Phase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic Melanoma
2013
Brain morphology alterations in the basal ganglia and the hypothalamus following prenatal exposure to antiepileptic drugs
2007

Author Peers

Author Last Decade Papers Cites
Tabea Wilhelm 294 248 50 85 9 485
Hai-Su Yang 265 195 48 47 17 461
Kate M. O’Neill 194 109 27 82 10 467
Jennifer L. Gilmore 307 291 31 49 13 571
Laurine E. Wedekind 264 125 36 86 15 499
Tullio Battista 240 129 40 53 11 526
Duane Currier 322 107 26 67 13 540
Gabriele Hübinger 198 76 66 36 11 489
Natasha Flores 297 110 24 48 12 424
R. Habets 351 177 27 160 8 526
Gergana Galabova‐Kovacs 357 90 50 55 8 467

All Works

Loading papers...

Rankless by CCL
2026